Go to the profile of Emilio I. Alarcon

Emilio I. Alarcon

Assistant Professor, University of Ottawa Heart Institute
  • University of Ottawa Heart Institute
  • (613) 696-7349
  • Contributors
  • Canada

About Emilio I. Alarcon

Dr. Alarcon was born in Santiago, Chile. He received his B.Sc. in Chemistry under the supervision of Professor Eduardo Lissi, the most cited Scientist in Chile, at Universidad de Santiago de Chile (2005) exploring the chemiluminescent mechanisms of tryptophan oxidation. He then pursued his MSc and PhD training in Chemistry, Pontificia Universidad Catolica de Chile (2009). Dr. Alarcon moved to Ottawa with his wife, where he undertook postdoctoral training (2009-2014) at Dr. Tito Scaiano’s laboratory, at the University of Ottawa. With his unique skills and vision for redefining translational research, Dr Alarcon was recruited to the Division of Cardiac Surgery at the University of Ottawa Heart Institute in July 2014 and became an Assistant Professor at the Faculty of Medicine at the University of Ottawa in 2015. Dr. Alarcon, though early in career, has already published over 74 articles (+40 since 2015 as an independent researcher) and +10 more are currently under review all in prestigious peer-reviewed journals (h-index is 21, i10 = 43), including Nature Communications, ACS Nano, ACS Applied Materials & Interfaces, Chemical Communications, Nanoscale, Nature Regenerative Medicine, to name a few. He has also published a number of book chapters, and acted as a lead editor for two books; Silver Nanoparticles on Biomedicine: ”Silver Nanoparticle Applications: In the Fabrication and Design of Medical and Biosensing Devices, ” 2015 (Springer), and “Nanoengineering Materials for Biomedical Uses,” 2019 (Springer Nature). Dr. Alarcon is also the founder of the first Live Streaming Science Radio from a laboratory: BEaTS Research Radio (http://www.beatsresearch.com/Radio.html), which aims to connect Scientist with their communities.


Biomaterials Biomechanics Biomedical imaging Medical devices Micro- and nanobiotechnology Nanomedicine

Intro Content

Contributor Nature Biomed Eng Nature Comms

An injectable gel that restores cardiac function after heart attack

Despite recent advancements in treatments and technologies, cardiovascular diseases (CVDs) still claim about 17 million lives per year. This makes CVDs the #1 cause of morbidity worldwide.


Channels contributed to:

Behind the paper